Roth Capital analyst George Kelly lowered the firm’s price target on BRC Inc. (BRCC) to $2 from $2.50 and keeps a Neutral rating on the shares after its Q1 results. Food, Drug, Mass segment business remains strong, but the firm sees elevated margin risk from green coffee inflation and tariffs, also finding it challenging to forecast the Energy drink ramp, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRCC:
- BRC Inc. Reports Q1 2025 Financial Results
- Buy Rating Justified by BRC Inc.’s Sales Resilience and Growth Potential Despite Mixed Earnings
- BRC Inc. reports Q1 adjusted EBITDA $0.9M vs. $12.5M last year
- BRC Inc. affirms FY25 revenue view of $395M-$425M, consensus $406.5M
- BRCC Earnings this Week: How Will it Perform?